By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Incyte Corporation 

Experimental Station
Route 141 & Henry Clay Road, Building E336
Wilmington  Delaware  19880  U.S.A.
Phone: 302-498-6700 Fax: 302-425-2750


Company News
Incyte (INCY) And Merck & Co. (MRK) Expand Clinical Collaboration To Include Phase 3 Study Investigating The Combination Of Epacadostat With Keytruda (Pembrolizumab) As First-Line Treatment For Advanced Melanoma 10/13/2015 12:52:34 PM
Incyte (INCY) To Report Third Quarter Financial Results 10/13/2015 11:05:32 AM
Data At SITC Annual Meeting To Highlight Progress Of Incyte (INCY)’s Immuno-oncology Portfolio 10/2/2015 10:08:31 AM
Data At SITC Annual Meeting To Highlight Progress Of Incyte (INCY)’s Immuno-Oncology Portfolio 10/2/2015 7:29:23 AM
Eli Lilly (LLY), Incyte (INCY) Rheumatoid Arthritis Drug Succeeds in Phase III Trial 9/29/2015 5:59:30 AM
Incyte (INCY) To Present At The Leerink Partners Inaugural Immuno-Oncology Roundtable Conference 9/15/2015 3:23:00 PM
Incyte (INCY) Release: MPN Awareness Day Raises Awareness And Support For The Nearly 300,000 People In The United States Affected By Rare Blood Cancers 9/10/2015 10:11:24 AM
Incyte (INCY), Jiangsu Hengrui Medicine Co. Ltd. Forge $795M+ Anti-PD-1 Monoclonal Antibody Pact 9/2/2015 10:42:56 AM
Incyte (INCY) To Present At Upcoming Investor Conferences 9/1/2015 9:01:19 AM
Incyte (INCY) Named 7th Most Innovative Company In The World By Forbes Magazine 8/21/2015 9:55:56 AM